Essential Tremor Followed by Progressive Supranuclear Palsy: Postmortem Reports of 11 Patients

被引:36
|
作者
Louis, Elan D. [1 ,2 ,3 ,4 ]
Babij, Rachel [3 ]
Ma, Karen [3 ]
Cortes, Etty [2 ]
Vonsattel, Jean-Paul G. [2 ,5 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Neurol, Neurol Inst, Unit 198, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, GH Sergievsky Ctr, New York, NY 10032 USA
[4] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[5] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
Essential tremor; Glial cytoplasmic inclusion; Movement disorder; Neurodegeneration; Parkinsonism; Progressive supranuclear palsy; Tau; RICHARDSON-OLSZEWSKI-SYNDROME; REST TREMOR; NINDS-SPSP; BRAIN; DIAGNOSIS; CRITERIA; PREVALENCE; DEMENTIA; RISK;
D O I
10.1097/NEN.0b013e31827ae56e
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
For many years, clinicians have commented on the development of signs of parkinsonism among their essential tremor (ET) patients, but the links between ET and parkinsonism are not well understood. We report 11 (12.4%) of 89 ET patients who were prospectively collected at the Essential Tremor Centralized Brain Repository during the course of its first 9 years. All patients had long-standing ET (median duration, 38 years); there was a 5- to 49-year latency from the onset of ET to the development of either parkinsonism or dementia. Despite the presence of parkinsonism or dementia during life, none had been diagnosed clinically with progressive supranuclear palsy (PSP). All 11 received the postmortem diagnosis of PSP. The prevalence of PSP in this ET sample (12.4%) is clearly larger than the population prevalence of PSP (0.001%-0.0065%). It is also 2 to 5 times the proportion of normal cases with incidental PSP in 2 previous autopsy series. This case series raises the questions of an association between ET and PSP, whether ET patients are at an increased risk of developing PSP, and what the proportion of ET patients who develop presumed Parkinson disease or Alzheimer disease in life actually have PSP (i.e. ET + PSP).
引用
收藏
页码:8 / 17
页数:10
相关论文
共 50 条
  • [41] STRIATED ANAL-SPHINCTER DENERVATION IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY
    VALLDEORIOLA, F
    VALLSSOLE, J
    TOLOSA, ES
    MARTI, MJ
    MOVEMENT DISORDERS, 1995, 10 (05) : 550 - 555
  • [42] Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy
    Brown, Richard G.
    Lacomblez, Lucette
    Landwehrmeyer, Bernard G.
    Bak, Thomas
    Uttner, Ingo
    Dubois, Bruno
    Agid, Yves
    Ludolph, Albert
    Bensimon, Gilbert
    Payan, Christine
    Leigh, Nigel P.
    BRAIN, 2010, 133 : 2382 - 2393
  • [43] Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy
    Park, LCH
    Albers, DS
    Xu, H
    Lindsay, JG
    Beal, MF
    Gibson, GE
    JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (05) : 1028 - 1034
  • [44] Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy
    Lee, Y.
    Lee, D. K.
    Lee, J. M.
    Chung, S. J.
    Lee, J. J.
    Sohn, Y. H.
    Lee, P. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (01) : 212 - 218
  • [45] Effect of gabapentin on oculomotor control and parkinsonism in patients with progressive supranuclear palsy
    Poujois, A.
    Vidailhet, M.
    Trocello, J.-M.
    Bourdain, F.
    Gaymard, B.
    Rivaud-Pechoux, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (09) : 1060 - 1062
  • [46] Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients
    dell'Aquila, Claudia
    Zoccolella, Stefano
    Cardinali, Valentina
    de Mari, Michele
    Iliceto, Giovanni
    Tartaglione, Bruno
    Lamberti, Paolo
    Logroscino, Giancarlo
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (11) : 980 - 985
  • [47] The comorbidity and co-medication profile of patients with progressive supranuclear palsy
    Greten, Stephan
    Wegner, Florian
    Jensen, Ida
    Krey, Lea
    Rogozinski, Sophia
    Fehring, Meret
    Heine, Johanne
    Doll-Lee, Johanna
    Poetter-Nerger, Monika
    Zeitzschel, Molly
    Hagena, Keno
    Pedrosa, David J.
    Eggers, Carsten
    Buerk, Katrin
    Trenkwalder, Claudia
    Claus, Inga
    Warnecke, Tobias
    Suess, Patrick
    Winkler, Juergen
    Gruber, Doreen
    Gandor, Florin
    Berg, Daniela
    Paschen, Steffen
    Classen, Joseph
    Pinkhardt, Elmar H.
    Kassubek, Jan
    Jost, Wolfgang H.
    Toenges, Lars
    Kuehn, Andrea A.
    Schwarz, Johannes
    Peters, Oliver
    Dashti, Eman
    Priller, Josef
    Spruth, Eike J.
    Krause, Patricia
    Spottke, Annika
    Schneider, Anja
    Beyle, Aline
    Kimmich, Okka
    Donix, Markus
    Haussmann, Robert
    Brandt, Moritz
    Dinter, Elisabeth
    Wiltfang, Jens
    Schott, Bjoern H.
    Zerr, Inga
    Baehr, Mathias
    Buerger, Katharina
    Janowitz, Daniel
    Perneczky, Robert
    JOURNAL OF NEUROLOGY, 2024, 271 (02) : 782 - 793
  • [48] IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome
    Mangesius, Stephanie
    Sprenger, Fabienne
    Hoftberger, Romana
    Seppi, Klaus
    Reindl, Markus
    Poewe, Werner
    PARKINSONISM & RELATED DISORDERS, 2017, 38 : 102 - 103
  • [49] Quantitative downgaze palsy predicts the survival duration in patients with progressive supranuclear palsy
    Xie, T.
    Yuen, C.
    Kang, W.
    Padmanaban, M.
    Han, T.
    Nichols, J.
    MOVEMENT DISORDERS, 2021, 36 : S258 - S258
  • [50] Effect of therapeutic exercise on the balance of patients with progressive supranuclear palsy: A pilot study
    Matsuda, Naomi
    Takamatsu, Yasuyuki
    Aiba, Ikuko
    FRONTIERS IN NEUROLOGY, 2022, 13